As U.S. stock futures dip this morning, the Dow futures trickle lower by over 50 points on Monday.
Li Auto Inc. ticker symbol LI ignited the pre-market session with a delightful spree, unveiling fourth-quarter financial results that outshone projections and unveiling optimistic first-quarter guidance.
The company showcased its prowess by delivering adjusted earnings of 30 cents per share, surpassing expectations of 29 cents per share. Li Auto’s quarterly sales rang in at a resounding $5.88 billion, leaving behind predictions of $5.48 billion.
In response, Li Auto’s shares galloped 8% higher to $37.56 in the pre-market hustle.
Exploring the lively pre-market scene, several big stocks were seen dancing in upward joy:
- ImmunityBio, Inc. ticker symbol IBRX joyfully climbed back by 12.3% to $3.93 after a slight stumble of 33% on Friday.
- Bowlero Corp. ticker symbol BOWL shares giggled up by 6.5% to $13.05 in pre-market trading.
- Teva Pharmaceutical Industries Limited ticker symbol TEVA shares sparkled with a 5.3% uptick to $13.57 in pre-market trading. Alvotech and Teva celebrated the U.S. approval of SIMLANDI®. for the first interchangeable high-concentration, citrate-free biosimilar to Humira.
- Amer Sports, Inc. ticker symbol AS shared the joyful rhythm with a 5.2% increase to $16.34 in pre-market trading following a 3% leap on Friday.
- SES AI Corporation ticker symbol SES ascended 5.1% to $1.45 in pre-market trading, with an anticipated release of its 2023 fourth quarter business results post the closing bell on Feb. 26, 2024.
- Berkshire Hathaway Inc. (NYSE: BRK-B) strode forward with a 5% surge to $438.08 in pre-market trading. Warren Buffett gleefully highlighted Berkshire’s intent to hold onto its investment in Occidental Petroleum indefinitely.
- BioCryst Pharmaceuticals, Inc. ticker symbol BCRX whisked up by 4.9% to $5.99 in pre-market trading as the company prepares to unveil its fourth quarter 2023 financial report on Feb. 26, 2024.
Now Read This: Investor Sentiment Edges Lower, But Fear & Greed Index Remains In ‘Extreme Greed’ Zone
Don’t forget to check out our premarket coverage here
